通过跨直流刺激修改抑制控制和渴望,作为药物使用障碍的附加治疗:随机对照研究的协议
Sabine Vollstädt-Klein1,2,3, Cagdas Türkmen4, Nadja Grundinger4
1Department of Addictive Behaviour and Addiction Medicine, Medical Faculty Mannheim, Central Institute of Mental Health, University of Heidelberg, PO Box 12 21 20, Mannheim, 68072, Germany. sabine.vollstaedt-klein@zi-mannheim.de.
BMC psychology
|October 14, 2025
概括
这项研究研究了对物质使用障碍 (SUD) 的跨直流刺激 (tDCS). 最佳的电极放置和极性可以减少认知缺陷和渴望,有助于预防复发.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 临床心理学 临床心理学
背景情况:
- 药物使用障碍 (SUD) 是一个重大的公共卫生挑战,复发率很高.
- 认知缺陷和渴望是导致SUD患者复发的关键因素.
- 目前对SUDs的治疗方法需要创新的策略来改善长期结果.
研究的目的:
- 确定用于治疗SUDs的跨直流刺激 (tDCS) 的最佳电极放置和极性.
- 调查tDCS在减少认知缺陷和物质渴望方面的有效性.
- 提高SUD的治疗结果,包括增加戒断期和减少复发率.
主要方法:
- 一项研究协议涉及162名年龄在18-65岁之间的人,他们符合DSM-5标准的酒精使用障碍 (AUD),包括并发性SUD.
- 随机分配给六组:无极tDCS (右/左DLPFC,侧皮层),假tDCS,计算机抑制训练,或通常的治疗 (TAU).
- 在基线,干预期间,干预后和四个随访点 (4,8,12,24周) 进行全面评估,测量渴望,抑制控制 (Go/No-Go任务),EEG活动 (N200,P300),戒断日和酒精消费.
主要成果:
- 主要结局侧重于渴望和抑制控制的变化,通过神经心理学任务和EEG进行评估.
- 二次结果包括治疗成功的客观指标,如戒断时间和减少酒精消费.
- 脑电图分析将专门研究与事件相关的潜力 (N200,P300),以了解神经机制.
结论:
- 这些发现可能会为SUD的未来治疗策略提供信息,并可能将tDCS作为复发预防工具进行整合.
- 成功实施需要通过强大的支持系统来解决参与者的舒适性和学率.
- 这项研究可以通过提供一种新的神经调节方法来推进SUD治疗.
相关概念视频
Blind Procedures
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Drug Abuse and Addiction: Pharmacological Phenomena
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications


